AI assistant
Sending…
Alkermes plc. — Director's Dealing 2019
Jun 10, 2019
31048_dirs_2019-06-10_0e90ebc4-0f19-4dfd-904d-2443b27f5263.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2019-06-07
Reporting Person: Hopkinson Craig C. (SVP, Med Dev/Med Affairs, CMO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-07 | Ordinary Shares | M | 1250 | — | Acquired | 7245 | Direct |
| 2019-06-07 | Ordinary Shares | F | 368 | $22.83 | Disposed | 6877 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-07 | Restricted Stock Unit Award | $0 | M | 1250 | Disposed | Ordinary Shares (1250) | Direct |
Footnotes
F1: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 6/7/18.
More from Alkermes plc.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 1
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27